6 July 20221 July 2022 mk2 Biotechnologies, WACKER and TUM jointly develop a process for the large-scale production of antimicrobial peptides based on sustainable fermentation The project particularly targets the development of new, highly potent AMPs, the development of a planetary circulating solid-liquid reactor, and the integration of both technologies into large-scale bio-production facilities
mk2 Biotechnologies, WACKER und TUM entwickeln gemeinsam Verfahren zur großtechnischen Produktion von anti-mikrobiellen Peptiden auf Basis nachhaltiger Fermentation Ziele des Projekts sind die Entwicklung neuer hochwirksamer AMPs, die Entwicklung eines planetar-zirkulierenden Fest-Flüssig-Reaktors sowie die Integration beider Technologien in großtechnische Bioproduktionsanlagen
10 August 20215 August 2021 mk2 Biotechnologies Receives a Multi-Million Sum in Seed Funding Company thrives to accomplish additional development milestones towards industrializing its novel peptide production platform